Characterisation of gut microbiota of obesity and type 2 diabetes in a rodent model

被引:13
|
作者
Ibrahim, Khalid S. [1 ,2 ]
Bourwis, Nowara [1 ]
Dolan, Sharron [1 ]
Lang, Sue [1 ,3 ]
Spencer, Janice [1 ]
Craft, John A. [1 ]
机构
[1] Glasgow Caledonian Univ, Dept Biol & Biomed Sci, Glasgow G4 0BA, Lanark, Scotland
[2] Univ Zakho, Fac Sci, Dept Biol, Zakho Int Rd, Duhok, Kurdistan Regio, Iraq
[3] Leeds Beckett Univ, Sch Clin & Appl Sci, Portland Bldg,City Campus, Leeds LS1 3HE, W Yorkshire, England
基金
英国工程与自然科学研究理事会;
关键词
butyrate; inflammatory molecules; microbiome; obesity; Type; 2; diabetes; HIGH-FAT DIET; INTESTINAL MICROBIOTA; MOLECULAR ANALYSIS; RATS; MODULATION; BUTYRATE; ONSET;
D O I
10.12938/bmfh.2019-031
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Various studies have suggested that the gut microbiome interacts with the host and may have a significant role in the aetiology of obesity and Type 2 Diabetes (T2D). It was hypothesised that bacterial communities in obesity and T2 D differ from control and compromise normal interactions between host and microbiota. Obesity and T2D were developed in rats by feeding a high-fat diet or a high-fat diet plus a single low-dose streptozotocin administration, respectively. The microbiome profiles and their metabolic potentials were established by metagenomic 16S rRNA sequencing and bioinformatics. Taxonomy and predicted metabolism-related genes in obesity and T2D were markedly different from controls and indeed from each other. Diversity was reduced in T2D but not in Obese rats. Factors likely to compromise host intestinal, harrier integrity were found in Obese and T2D rats including predicted, decreased bacterial butyrate production. Capacity to increase energy extraction via ABC-transporters and carbohydrate metabolism were enhanced in Obese and T2D rats. T2D was characterized by increased p ruin flammatory molecules. While obesity and T213 show distinct differences, results suggest that in both conditions Bacteroides and Blautia species were increased indicating a possible mechanistic link.
引用
收藏
页码:65 / 74
页数:10
相关论文
共 50 条
  • [41] Obesity and Type 2 Diabetes affect the Gut Virome
    Lichert, Frank
    AKTUELLE ERNAHRUNGSMEDIZIN, 2022, 47 (03):
  • [42] Considering gut microbiota in treatment of type 2 diabetes mellitus
    Adeshirlarijaney, Aneseh
    Gewirtz, Andrew T.
    GUT MICROBES, 2020, 11 (03) : 253 - 264
  • [43] Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus
    Zhou, Zheng
    Sun, Bao
    Yu, Dongsheng
    Zhu, Chunsheng
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [44] Dysbiosis and Regulation of Gut Microbiota in Type 2 Diabetes Mellitus
    Minakshi, Hemlata
    Kumari, Hemlata
    Prakash, Shaurya
    Kumar, Antresh
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2024,
  • [45] Factors Influencing the Gut Microbiota, Inflammation, and Type 2 Diabetes
    Wen, Li
    Duffy, Andrew
    JOURNAL OF NUTRITION, 2017, 147 (07): : 1468S - 1475S
  • [46] Altered Gut Microbiota in Type 2 Diabetes: Just a Coincidence?
    Sircana, Antonio
    Framarin, Luciana
    Leone, Nicola
    Berrutti, Mara
    Castellino, Francesca
    Parente, Renato
    De Michieli, Franco
    Paschetta, Elena
    Musso, Giovanni
    CURRENT DIABETES REPORTS, 2018, 18 (10)
  • [47] Response of gut microbiota in type 2 diabetes to hypoglycemic agents
    Zhang, Fanghua
    Wang, Meng
    Yang, Junjie
    Xu, Qian
    Liang, Cheng
    Chen, Bin
    Zhang, Jiaming
    Yang, Ying
    Wang, Huiling
    Shang, Yongfang
    Wang, Ye
    Mu, Xiaofeng
    Zhu, Dequan
    Zhang, Chunling
    Yao, Minxiu
    Zhang, Lei
    ENDOCRINE, 2019, 66 (03) : 485 - 493
  • [48] Gut microbiota and immunopathogenesis of diabetes mellitus type 1 and 2
    Wang, Fei
    Zhang, Chunfang
    Zeng, Qiang
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2016, 21 : 900 - 906
  • [49] Pharmacologic and Nonpharmacologic Therapies for the Gut Microbiota in Type 2 Diabetes
    Caesar, Robert
    CANADIAN JOURNAL OF DIABETES, 2019, 43 (03) : 224 - 231
  • [50] Role of the gut microbiota in type 2 diabetes and related diseases
    Yang, Ge
    Wei, Jinlong
    Liu, Pinyi
    Zhang, Qihe
    Tian, Yuan
    Hou, Guowen
    Meng, Lingbin
    Xin, Ying
    Jiang, Xin
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 117